Nizoral is the highest-leverage cheap add-on in hair care: a mainstream 1% ketoconazole dandruff shampoo whose active ingredient happens to have genuine supporting data in male-pattern hair loss. In Pierard-Franchimont 1998, long-term 2% ketoconazole improved hair density, shaft diameter, and the proportion of anagen follicles to a degree comparable with 2% minoxidil. The mechanism is real — anti-inflammatory action plus a local anti-androgen effect on the scalp — not a marketing story. At roughly $4 a month of use (two washes a week from a $15 bottle), the value-to-evidence ratio is the best on this page. What it is not is a standalone regrowth agent: it's the reliable #2 that supports minoxidil, not a hero that replaces it.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Looksmaxxing guide →Real adjunct evidence, a notch below minoxidil's. Pierard-Franchimont 1998 (PMID 9669136) found long-term 2% ketoconazole improved density, shaft diameter and anagen fraction comparably to 2% minoxidil in AGA. Supportive rather than definitive — the trial base is smaller and the OTC product is 1%, not the 2% studied.
A genuine, plausible mechanism: ketoconazole is antifungal and anti-inflammatory and appears to blunt local scalp androgen activity. It acts on real drivers of loss (inflammation, DHT), not a hand-wavy 'phyto-active' story.
Excellent tolerability at twice-weekly use — this is a mainstream OTC dandruff shampoo. The only honest caveat is dryness with overuse; alternate with a normal conditioner and don't use daily. Near-zero systemic risk.
About $4 a month of use from a ~$15 bottle — outstanding value for a product with real supporting data. On SAC's quality-over-price rule, the low price is a bonus on top of genuine evidence, not a substitute for it.
Nearly free adherence: swapping your shampoo twice a week fits into a life with no new habit to build. Far easier to sustain than a twice-daily solution — the routine is the reason it scores high here.
“Clinically shown to help androgenetic alopecia.”
Supported but with caveats. Pierard-Franchimont 1998 (PMID 9669136) studied 2% ketoconazole and found density/anagen gains comparable to 2% minoxidil. The OTC Nizoral is 1%, and the evidence positions ketoconazole as an adjunct, not a standalone cure. True in direction, softened in strength.
“Reduces DHT on the scalp.”
Plausible and supported by mechanistic literature — topical ketoconazole appears to blunt local androgen activity and inflammation — but the effect size in humans is modest and less characterized than finasteride's systemic DHT reduction. Directionally fair, not a strong anti-DHT drug.
“Controls dandruff and flaking.”
This is ketoconazole's core, well-established OTC indication. Reducing the flaking and inflammation that sabotage adherence is itself useful for a hair regimen.
“Thickens and strengthens hair.”
Consistent with the density/shaft-diameter gains in Pierard-Franchimont 1998, but that trial used 2% and framed the effect as adjunctive. As a cosmetic 'thickening' claim on a 1% OTC shampoo it's optimistic; as an adjunct effect it's defensible.
Ketoconazole's supporting data in AGA is the reason Nizoral sits at #2. Pierard-Franchimont 1998 (PMID 9669136) found 2% ketoconazole improved hair density, shaft diameter and anagen fraction comparably to 2% minoxidil — a genuine result for a product most people buy for flakes.
The evidence positions ketoconazole as support for minoxidil, not a replacement. On its own it won't regrow a scalp; layered onto a minoxidil regimen it lowers the inflammation and local DHT that work against you. Buy it as leg two of the stack, not as a hero.
At roughly $4 a month of use, Nizoral gives you real supporting data for less than a coffee. That's not 'cheap therefore good' — it's genuine evidence that also happens to be inexpensive, which is exactly the combination SAC rewards.
Use it two times a week, leave it on 3-5 minutes, then rinse; alternate with a normal conditioner. Daily use can dry the scalp and hair without adding benefit. The twice-weekly cadence is both the studied pattern and near-effortless to sustain.
Nizoral is the highest-leverage cheap adjunct on this list: a mainstream dandruff shampoo whose active has real supporting data in male-pattern loss. It won't regrow a scalp alone, but as the second leg of a minoxidil regimen it lowers scalp inflammation and local DHT for about four dollars a month, with near-zero downside. There is almost no reason not to swap your shampoo twice a week. Buy it as the dependable #2 to minoxidil's #1 — not a hero product, but the adjunct with the best evidence-to-price ratio here. Pair it with Kirkland minoxidil (#1) and a derma roller (#3) and you've built essentially the best consumer regimen that exists for under $20 a month.
Check Nizoral · 1% ketoconazole anti-dandruff shampoo · 7 fl oz on AmazonThe proven foundation Nizoral supports — the only OTC ingredient FDA-approved to regrow men's hair. Buy this first; Nizoral is the adjunct.
See it on the list →The other cheap multiplier — microneedling quadrupled minoxidil's gains in Dhurat 2013. Stacks cleanly alongside a ketoconazole wash.
See it on the list →A natural option with one real trial (Panahi 2015); a gentle, low-irritation add-on if you want a botanical alongside your shampoo.
See it on the list →Long-term 2% ketoconazole shampoo improved hair density, shaft diameter and the proportion of anagen follicles in AGA to a degree comparable with 2% minoxidil, alongside reduced scalp sebum. The evidence behind ranking ketoconazole shampoo as a genuine, cheap adjunct rather than a placebo.
48-week RCT establishing 5% minoxidil as the proven OTC regrowth agent. The benchmark ketoconazole is compared against and, as an adjunct, supports rather than replaces.
Microneedling + minoxidil roughly quadrupled hair count vs minoxidil alone at 12 weeks — the third leg of the cheap, evidence-backed regimen Nizoral fits into.
